Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gas Sensing Capsule Could Uphold Gut Health

By LabMedica International staff writers
Posted on 22 Mar 2015
A novel ingestible capsule can measure the concentration of selected intestinal gases, opening new possibilities for diagnosis, treatment, and health analysis.

Developed by researchers at RMIT University (Melbourne, Australia) and Monash University (Melbourne, Australia), the capsule features bio-compatible cladding, a gas permeable membrane, gas sensor, electronic circuits such as sensor drivers, micro-controllers, wireless high-frequency transmission electronics, and a battery. More...
Animal trials have demonstrated the effectiveness and safety of the capsules, which transmit data as they move through the gut to a handheld device such as a mobile phone, before passing out of the body.

Currently, doctors rely on indirect measurements, such as breath and fecal analysis, to gauge which gases are in the intestine. But an ingested sensor could directly analyze the gases released when bacteria ferment undigested food in the gut, such as carbon dioxide (CO2), hydrogen, methane, oxygen, and hydrogen sulphide. Supporting apps could have libraries that compare fractional gas concentrations in various states, so that the relative changes would indicate certain diseases or intestinal conditions. The study describing the capsule was published on March 12, 2015, in Trends in Biotechnology.

“A gas-sensing pill could give you a real-time glimpse into what’s going on in your gut; as the gases permeate the capsule, the sensors produce signals and digitize the data, then send it to an app,” said senior author Prof. Kourosh Kalantar-Zadeh, PHD, of RMIT. “If some organic compound like butyrate goes up, that means something is happening to the wall of the stomach, and the thing that is happening is generally not good, has to be detected, and should be addressed very quickly.”

“We know gut microorganisms produce gases as a by-product of their metabolism, but we understand very little about how that affects our health,” added Prof. Kalantar-Zadeh. “Being able to accurately measure intestinal gases could accelerate our knowledge about how specific gut microorganisms contribute to gastrointestinal disorders and food intake efficiency, enabling the development of new diagnostic techniques and treatments.”

Intestinal gases have been linked to colon cancer, irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), and could potentially be used as key biomarkers for assessing overall health.

Related Links:

RMIT University
Monash University



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.